Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

President and CEO

Chief Financial Officer

Omega Therapeutics, Inc. operates as a clinical-stage biotechnology company. The company's OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by restoring aberrant gene expression to a range without altering native nucleic acid sequences. It also develops OTX-2002 for hepatocellular carcinoma; OTX-2101 for non-small cell lung cancer; omega epigenomic controllers (OEC) for inflammatory lung diseases, such as neutrophilic asthma, acute respiratory distress syndrome, dermatological, oncology, and rheumatological indications; OEC candidates for idiopathic pulmonary fibrosis; liver regeneration medicines; and OEC candidates for patients with diabetes and other conditions to treat corneal epithelial injury. In addition, the company develops OEC candidates for the treatment of alopecia, a disorder characterized by patches of non-scarring hair loss affecting the scalp and body. Omega Therapeutics, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Omega Therapeutics, Inc. operates as a clinical-stage biotechnology company.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2023-06-02	Premium	sold	Premium	Premium	Premium	-
2023-05-01	Premium	sold	Premium	Premium	Premium	-
2023-04-06	Premium	sold	Premium	Premium	Premium	-
2023-03-17	Premium	sold	Premium	Premium	Premium	-
2023-02-27	Premium	bought	Premium	Premium	Premium	-
2023-02-27	Premium	bought	Premium	Premium	Premium	-
2023-01-10	Premium	sold	Premium	Premium	Premium	-
2022-09-14	Premium	sold	Premium	Premium	Premium	-
2022-02-01	Premium	acquired	Premium	Premium	Premium	President and CEO
2021-08-03	Premium	bought	Premium	Premium	Premium	-
2021-08-03	Premium	bought	Premium	Premium	Premium	-
2021-08-03	Premium	acquired	Premium	Premium	Premium	-
2021-08-03	Premium	acquired	Premium	Premium	Premium	-
2021-08-03	Premium	bought	Premium	Premium	Premium	-
2021-08-03	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2021-07-30	Premium	bought	Premium	Premium	Premium	-

OMGA - Omega Therapeutics, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for OMGA